BMA vs BUSE Stock Comparison
BUSE currently leads BMA in this stock comparison, with AIQ scores of 66 vs 47. The clearest difference is momentum, while BMA has the stronger quality profile.
What is the main difference between BMA and BUSE?
BUSE leads the current stock comparison as First Busey Corporation, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Banco Macro S.A. vs First Busey Corporation
BUSE leads
BUSE leads by 19 AIQ points, primarily on Momentum and Risk Resilience.
Stable: 5 of 5 evidence groups support BUSE.
Banco Macro S.A.
First Busey Corporation
The Algovestiq AIQ Score currently favors BUSE over BMA, 66 versus 47 as of Nov 15, 2026. BUSE's advantage is driven primarily by stronger momentum and risk resilience, while BMA holds the stronger quality profile. BUSE also shows the stronger technical structure relative to its 50-day moving average. 5 of 5 covered evidence groups favor BUSE today, and the comparison is rated Stable on stability.
Compare Banco Macro S.A. and First Busey Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare BMA and BUSE against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum18 vs 60BUSE +42
- Risk Resilience49 vs 89BUSE +40
- Quality71 vs 57BMA +14
- Value61 vs 72BUSE +11
5 of 5 evidence groups favor BUSE. BUSE’s edge is concentrated in momentum and risk resilience; BMA keeps a meaningful quality edge.
The central trade-off
BUSE (First Busey Corporation): the stronger current systematic profile, led by momentum and risk resilience.
BMA (Banco Macro S.A.): the counter-case, on quality — but at materially higher volatility, 40.4% against 24.3%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BUSEBUSE on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BUSEBUSE on combined revenue and EPS growth.
Value
BUSEBUSE on the peer-relative Value factor, by 11 points.
Momentum
BUSEBUSE on the Momentum factor, by 42 points.
Lower downside
BUSEBUSE on Risk Resilience, by 40 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BMA | BUSE | Note |
|---|---|---|---|
| Implied upside to target | +60% | — | Level |
| Target dispersion | 0% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 9 | 7 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 5 covered evidence groups favor BUSE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | BUSE | 47 vs 66 |
| Fundamentals | BUSEon balance | revenue growth -23% vs 157.6%; EPS growth 45.6% vs -4.6%; TTM ROE 3.3% vs 2.5%; gross margin 56.9% vs 65.6%; operating margin 10.5% vs 16.2% — BUSE takes 3 of 5 decided legs, not all of them |
| Valuation | BUSE | Value 61 vs 72 |
| Technicals | BUSE | Price vs 50-day -14.6% vs -2.5%; vs 200-day -27.7% vs 2.6% |
| Risk Resilience | BUSE | Risk Resilience 49 vs 89 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BMA and BUSE and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 19 points. (supports the conclusion holding)
- 5 of 5 covered evidence groups point the same way. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BUSE.
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BMA closes the Momentum gap — currently 42 points behind, the largest single contributor to BUSE's edge.
- 2BMA generates a confirmed bullish trend signal it does not currently carry, such as Golden Cross Active or MACD Bullish Crossover.
- 3BUSE starts generating bearish momentum or trend signals.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BUSE leads on balance| Metric | BMA | BUSE |
|---|---|---|
| Revenue growth (YoY) | -23% | 157.6% |
| EPS growth (YoY) | 45.6% | -4.6% |
| Gross margin | 56.9% | 65.6% |
| Operating margin | 10.5% | 16.2% |
| Return on equity (TTM) | 3.3% | 2.5% |
| Debt to equity | 0.27 | 0.2 |
Performance
BUSE leads 6 of 6 windows| Metric | BMA | BUSE |
|---|---|---|
| 1 week (5 sessions) | -1.6% | 0.8% |
| 1 month (20 sessions) | -11.2% | -1.9% |
| 3 months (63 sessions) | -27.9% | -7.1% |
| 6 months (126 sessions) | -19.7% | 11.9% |
| Year to date | -36.9% | 21.4% |
| 1 year (252 sessions) | -34.1% | 24.7% |
Technicals
BUSE has the stronger structure| Metric | BMA | BUSE |
|---|---|---|
| RSI (14) | 35.2 | 44.2 |
| ADX (14) | 34.4 | 13.6 |
| Price vs 50-day | -14.6% | -2.5% |
| Price vs 200-day | -27.7% | 2.6% |
| Volatility (1M, annualized) | 40.4% | 24.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BMA or BUSE?
On the Algovestiq AIQ Score, BUSE is the stronger of the two as of Nov 15, 2026, scoring 66 against BMA's 47. The edge comes from momentum and risk resilience. BMA is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BMA or BUSE the better buy right now?
BUSE carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor BUSE over BMA?
The composite weights Quality, Value, Momentum and Risk Resilience. BUSE leads Momentum by 42 points; BUSE leads Risk Resilience by 40 points; BMA leads Quality by 14 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BMA or BUSE?
Analyst price targets imply +60% upside for BMA and not covered for BUSE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BMA or BUSE?
BUSE is the better-valued of the two on the peer-relative Value factor. BUSE on the peer-relative Value factor, by 11 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BMA or BUSE?
BUSE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BMA or BUSE?
BUSE on the Momentum factor, by 42 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BMA or BUSE?
BUSE is the more resilient of the two, so the other name carries the higher downside risk. BUSE on Risk Resilience, by 40 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BMA more profitable than BUSE?
The profitability evidence is mixed: gross margin 56.9% vs 65.6%; operating margin 10.5% vs 16.2%; ttm roe 3.3% vs 2.5%. BMA leads on one measure and BUSE on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
What would change the BMA vs BUSE verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BMA closes the Momentum gap — currently 42 points behind, the largest single contributor to BUSE's edge; BMA generates a confirmed bullish trend signal it does not currently carry, such as Golden Cross Active or MACD Bullish Crossover; BUSE starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
Compare BMA and BUSE with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.